• Profile
Close

Microvascular disease in patients with diabetes with heart failure and reduced ejection vs preserved ejection fraction

Diabetes Care Jul 17, 2019

Tromp J, et al. - In patients with heart failure (HF) and diabetes mellitus (DM), researchers studied the prevalence of microvascular complications and how they are linked with clinical outcomes. In 2,800 prospectively enrolled participants with HF and DM (561 with HF with preserved ejection fraction [HFpEF]) from the ASIAN-HF registry, they examined the prevalence, association with clinical outcome, and cardiac structure and function of microvascular complications (neuropathy, nephropathy, and retinopathy). There were microvascular complications in a total of 601 participants with DM. Investigators found that diabetic microvascular disease is more common in participants with HFpEF vs HF with reduced ejection fraction and is associated with greater LV remodeling, greater quality of life impairment, and similar adverse outcomes. They suggested that HFpEF can be a clinical manifestation of DM's microvascular disease.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay